Skip to Content
Biotechnology and health

The CRISPR books racing to be the technology’s definitive guide

Stack of books
Stack of booksMaxpixel

The CRISPR story has arrived for the grand telling as a miracle of our age. The proof? At least four popular, mass-market books about the DNA-snipping technology are under way.

Details on the book projects are limited, but they all seem to tease the idea that human evolution itself is at stake now that scientists have the power to alter our genes.

The CRISPR babies born in China last year made that topic more urgent than ever. Now, these four book authors will be in their own CRISPR race to see who publishes first. Here’s the rundown of what we know. 

Untitled, by Walter Isaacson

Sources tell us that Isaacson, the biographer of Albert Einstein, Leonardo da Vinci, and Steve Jobs, is having a close look at the CRISPR story, possibly through the eyes of Jennifer Doudna, the University of California biochemist who co-invented the tool and then started warning the world how it could be misused.

We don’t know if the book has a working title, but according to our sources, Isaacson has been in Europe interviewing CRISPR scientists including Emmanuel Charpentier, who teamed with Doudna to make a key CRISPR breakthrough. Since CRISPR’s invention was more a group effort than the work of a solitary scientist, the story may be hard to present as a “genius biography,” Isaacson's specialty. 

Neither Isaacson nor his agent, Amanda “Binky” Urban, at ICM Partners in Manhattan, responded to messages. What’s certain, though, is that Isaacson’s famous name and big-picture pen could put the CRISPR story onto the best-seller list. Expect a seven-figure book deal. 

Editing Mankind: Humanity in the Age of CRISPR and Gene Editing, by Kevin Davies

Davies is the editor of the academic CRISPR Journal and previously wrote The $1,000 Genome, a book about the race to make DNA sequencing faster and cheaper. Davies has now sold a CRISPR book to Pegasus Books that is going to have a look at gene-editing research in China and the US and will ask whether scientists are “playing God.”

According to a blurb, the book, due out next year, will track “the scientists on the front lines of its research to the patients whose powerful stories bring the narrative movingly to human scale.” 

Davies has had a ringside seat on CRISPR, including last year’s gene-editing debacle in China. His journal published a lengthy paper on the ethics of genetically modifying humans by He Jiankui, the Chinese scientist who revealed he’d made gene-edited twins. The journal eventually retracted He's paper for serious ethics and conflict of interest violations.

Mutants, by Eben Kirksey

Kirksey is a cultural anthropologist who will be spending the next academic year at the Institute for Advanced Study, in Princeton, New Jersey. He will be looking at the intersection of gene editing and social inequality, which is going to be a problem if only some people can afford to upgrade their genes. According to a publisher’s listing, Kirksey “plans a deep dive into the international case of scientists, lobbyists, entrepreneurs, and activists remaking the human race through CRISPR.”

The book was sold to St. Martin’s press, according to our sources, but neither Kirksey nor his publisher immediately responded to email messages.

Untitled, by Michael Specter  

We’ve been hearing for some time that New Yorker scribe Michael Specter is at work on a CRISPR book, and we’ve spotted him shadowing MIT gene-drive specialist Kevin Esvelt, who has been outspoken when it comes to releasing gene-editing tools in the environment—for instance, to eliminate malaria-transmitting mosquitoes in Africa. Specter previously profiled Esvelt for the New Yorker. Specter did not immediately return an email seeking comment. 

Maybe I should write a book myself. I am thinking CRISPR for Dummies meets Mary Shelley.

Deep Dive

Biotechnology and health

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

A biotech company says it put dopamine-making cells into people’s brains

The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.

Tiny faux organs could crack the mystery of menstruation

Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.

How AI can help us understand how cells work—and help cure diseases

A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.